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ABstrAct
Lesions of salivary glands with a prominent lymphoid component are a heterogeneous group of diseases that include 
benign reactive lesions and malignant neoplasms. Occasionally, these pathologic entities present difficulties in the clinical 
and pathological diagnosis and prognosis. Lymphoepithelial sialadenitis, HIV-associated salivary gland disease, chronic 
sclerosing sialadenitis, Warthin tumor, and extranodal marginal zone B-cell lymphoma are examples of this pathology 
that are sometimes problematic to differentiate from one another. In this paper the author reviewed the main clinical, 
pathological and prognostic features of these lesions.
Key words:  Lymphoepithelial sialadenitis, HIV-associated salivary gland disease, chronic sclerosing sialadenitis, Warthin 
tumor, extranodal marginal zone B-cell lymphoma.
Indexed in: 
-Index Medicus / MEDLINE  /  PubMed            
-EMBASE, Excerpta Medica
-SCOPUS
-Indice Médico Español                                                        
-IBECS
              Article Number: 9996143853
              © Medicina Oral S. L. C.I.F. B 96689336 - ISSN 1698-6946 
              eMail:  medicina@medicinaoral.com 
IntroductIon
Lymphocytic infiltrates of the major salivary glands are 
involved in a spectrum of diseases that range from reactive 
to benign and malignant neoplasms. In many cases, the 
lymphocytic infiltrate is a minor inflammatory component 
that is easily distinguished from the primary disease pro-
cesses. In some cases, however, the lymphocytic infiltrate 
is a major component of the disease, and histopathologic 
features that distinguish reactive and benign lesions from 
malignant lesions are often subtle. Lymphoepithelial sia-
ladenitis (as occurs in Sjögren syndrome), HIV-associated 
sialadenitis, and extranodal marginal zone B-cell lymphoma 
are good examples of diagnoses that are often problematic 
to differentiate from one another. In this paper, benign 
and malignant diseases of salivary gland with a prominent 
lymphocytic component will be discussed with an emphasis 
on their distinguishing histopathologic featurers and diffe-
rential diagnoses.
MArGInAL ZonE B-cELL LyMphoMA
Clinical features. Lymphomas are malignant neoplastic 
proliferations of lymphocytes. When major salivary glands 
are involved, they are commonly the first clinical manifesta-
tion of disease, and disease is often confined to the salivary 
glands. Because normal parotid glands contain intra-paren-
chymal nodal tissue, some parotid lymphomas have a nodal 
origin, but most do not. Salivary gland involvement by 
Hodgkin lymphoma is rare and probably always secondary 
to nodal disease outside of the salivary glands.(1)
Lymphomas are a significant proportion of malignancies of 
the major salivary glands, accounting for 1.7 to 7.7 percent 
of tumors.(1) Use of flow cytometry, immunohistochemis-
try, and other molecular studies has most likely increased 
the frequency of diagnosis of lymphoma.
Patients with autoimmune disease, particularly Sjögren 
syndrome, have a markedly increased risk of developing 
lymphoma, which may be 44 times greater than in the ge-
neral population.(1) However, most patients with salivary 
lymphomas do not have Sjögren syndrome.(2) Viral DNA 
in lymphomatous tissue or increased antibody titers against 
virus have been detected in some patients.(3)
Females are affected more than males, especially when there 
is preceding autoimmune disease, as is the case with margi-
nal zone B-cell lymphomas. Disease in children is rare, and 
patients average 63 years of age. Patients often have diffuse 
glandular enlargement, which is sometimes bilateral.(1) 
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Pathologic features. Most salivary lymphomas are non-
Hodgkin, B-cell lymphomas, and T-cell lymphomas are 
rare.(4) Many different types of lymphoma occur, but the 
majority is extranodal marginal zone B-cell lymphoma. 
Follicular and diffuse large B-cell lymphomas comprise 
most of the others.(1)
Proliferating lymphocytes alter the normal lobular salivary 
gland architecture, replace acini and ducts, surround nerves, 
and infiltrate into fat and interlobular and periglandular 
connective tissues. Marginal zone B-cell lymphomas are 
composed of small lymphocytes that proliferate as multiple 
foci or large confluent sheets. The neoplastic cells are post-
germinal center B-cell lymphocytes, which in their normal, 
non-neoplastic state are destined to differentiate to plasma 
cells. These neoplastic lymphocytes are slightly larger than 
normal small lymphocytes and have a centrocyte-like or 
monocytoid appearance. The latter have pale-stained cyto-
plasm, which makes them conspicuous in histologic sections. 
Most, if  not all, marginal zone B-cell lymphomas arise 
within pre-existing lymphoepithelial sialadenitis, which is 
the histopathologic presentation of autoimmune sialadenitis 
and acquired mucosal associated lymphoid tissue (MALT). 
Most of the salivary parenchyma is destroyed, but some 
hyperplastic ductal epithelium persists and is permeated by 
neoplastic lymphocytes, so called lymphoepithelial lesions. 
An emerging MZBCL is recognized by foci of expansion 
of marginal zone B-cells around lymphoepithelial lesions. 
Typically associated with the neoplastic lymphocytic pro-
liferation is a non-neoplastic lymphoid infiltrate of T-cells, 
B-cells, plasma cells, reactive germinal centers, and scattered 
centroblasts or immunoblasts. 
The neoplastic marginal zone lymphocytes are immuno-
reactive for CD20 and CD79a and non-reactive for CD3, 
UCHL-1, and cyclin D1. They are usually negative for CD5, 
CD10, and CD23, but frequently express CD43. Most cases 
express monotypic surface immunoglobulin.(5) The epithe-
lial component of the lymphoepithelial lesions is reactive 
for cytokeratin. 
Gene translocations t(11;18)(q21;q21) and t(1;14)(p22;q32) 
are frequent in gastric and pulmonary marginal zone lym-
phomas but rare in those of salivary glands. Translocation 
t(14;18)(q21;q32) of the MLT/MALT1 gene and immuno-
globulin heavy chain locus is relatively frequent in tumors 
of the parotid.(2,6)  
Prognosis. Salivary MZBCL lymphoma is rather indolent 
and usually remains localized. Some patients are cured 
with local therapy, and spontaneous regression has been 
reported.(1,7) Transformation of low-grade marginal zone 
lymphomas to higher grade, diffuse large B-cell lymphomas 
sometimes occurs.
Other types of lymphomas that occur in the salivary glands 
have a prognosis similar to nodal lymphomas. 
Differential Diagnosis. The two principal considerations in 
the differential diagnosis are lymphoepithelial sialadenitis 
and HIV-associated sialadenitis (see below). The lympho-
cytic infiltrate in chronic sclerosing sialadenitis tends not 
to alter the glandular lobular architecture or surrounding 
tissue. Immunostaining for MT-2, bcl-2, and CD10 helps 
distinguish follicular lymphoma. 
LyMphoEpIthELIAL sIALAdEnItIs
Clinical features. Lymphoepithelial sialadenitis is a benign 
lymphocytic infiltrate of salivary gland with parenchymal 
atrophy and foci of ductal hyperplasia with lymphocytic 
epitheliotropism. The lymphocytic infiltrate is the saliva-
ry manifestation of  mucosa-associated lymphoid tissue 
(MALT), which in the salivary glands is acquired MALT. It 
is an autoimmune lesion and a component of Sjögren syn-
drome. Sjögren syndrome is an autoimmune disease complex 
that includes lacrimal and salivary gland disease, keratocon-
junctivitis sicca, xerostomia, and serum autoantibodies like 
anti-SSA, anti-SSB, rheumatoid factor, and salivary duct 
antibodies. Sjögren syndrome is sometimes associated with 
other autoimmune diseases and called secondary Sjögren 
syndrome. It affects women 3:1 over men. It occurs most 
frequently in the fourth to seventh decades of life and affects 
parotid glands in about 90% of cases.(1)
Bilateral disease is typical, although one gland may be more seve-
rely affected. Patients experience recurring and often progressive 
swelling and sometimes experience discomfort or pain.
Pathologic features. Lymphocytic infiltration, parenchymal 
atrophy, and foci of  epithelial proliferation characterize 
lymphoepithelial sialadenitis. The lobular architecture of the 
gland is usually preserved. In the early stages, the extent of 
lymphocytic infiltrate varies among lobules of gland, but in 
late stage disease, nearly all of the parenchyma is infiltrated. 
The number of lymphoid germinal centers varies from few 
to numerous. Multiple foci of ductal epithelial hyperplasia 
are permeated by lymphocytes, lymphoepithelial lesions. 
Within the lymphoepithelial lesions, lumens are sometimes 
evident, but most are irregularly shaped islands of polygo-
nal and spindled cells, often with deposits of intercellular 
eosinophilic hyalin material. The hyperplastic epithelium 
is predominantly ductal basal cells that lack immunohisto-
chemical markers specific to myoepithelium.
The lymphoid infiltrate has a predominance of T-cells, but 
within the foci of epithelial proliferation, lymphocytes have 
features of monocytoid B-cells or centrocyte-like cells, i.e. 
marginal zone B-cells. In some cases, some foci of intra-epi-
thelial B-cell infiltration are clonal;(8) however, in the absence 
of expansion of these B-cell clones, it is controversial whether 
they represent the very earliest manifestation of lymphoma. 
In Sjögren syndrome, minor salivary glands manifest chro-
nic sialadenitis but typically lack lymphoepithelial lesions. 
Labial minor salivary gland biopsy is commonly used, in 
conjunction with other clinical and laboratory parameters, 
for assessment of Sjögren syndrome (Table 1).(9) One or 
more foci of 50 or more lymphocytes per 4mm2 of salivary 
gland tissue are supportive of Sjögren syndrome. 
The majority of lymphocytes are reactive with T-cell mar-
kers while the lymphocytes in and around the lymphoepi-
thelial lesions are mostly reactive with B-cell markers. Foci 
of epithelial hyperplasia are reactive for cytokeratin but are 
unreactive for myoepithelial specific markers.
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Prognosis. Lymphoepithelial sialadenitis and Sjögren 
syndrome are not curable but are often controllable with 
anti-inflammatory therapies, such as corticosteroids.(10) 
These patients have a much higher risk of development of 
lymphoma, and most, if  not all, salivary extranodal MZB-
CLs are preceded by lymphoepithelial sialadenitis. 
Differential Diagnosis. Extranodal MZBCL is the principal 
differential diagnosis. In the earliest stage of transition to 
lymphoma, distinction is difficult and diagnostic features 
are not well defined, but expansion of clonal monocytoid or 
centrocyte-like B-cells around lymphoepithelial complexes 
is considered diagnostic. In more advanced disease, the 
areas of marginal zone B-cell expansion become confluent. 
The foci of epithelial hyperplasia persist. Distinction from 
lymphoepithelial sialadenitis (LESA) is based on the num-
ber and distribution of  marginal zone and monocytoid 
B cells. In lymphoma, they are located outside, as well as 
within, the lymphoepithelial lesions, as surrounding halos 
and anastomosing strands that often interconnect several 
different lymphoepithelial lesions. Sometimes follicles are 
extensively infiltrated by marginal zone B cells. Furthermo-
re, unlike LESA, there are often sheets of plasma cells with 
or without Dutcher bodies.(2)
The histopathologic features of  HIV-associated salivary 
gland disease are also remarkably similar to LESA (see 
below).
HIV-ASSOCIATED SALIVARy GLAND DISEASE
HIV-associated salivary gland disease (HSGD) is a lymphoid 
hyperplasia in the parotid, and sometimes submandibular, 
glands with lymphoepithelial cysts and lymphoepithelial 
lesions in HIV+ patients. This has also been called salivary 
diffuse infiltrative lymphocytosis syndrome.(1,11)
Clinical features. The incidence of HIV-associated salivary 
gland disease is 3 to 10% among HIV infected patients, but the 
incidence may be influenced by the availability of anti-viral 
therapy.(11) Children and adults and males and females are 
affected. Patients have been intravenous drug users, homo-
sexual men, heterosexual women and men, transfusion reci-
pients, and congenitally infected. Salivary gland involvement 
in HIV+ patients may be related to viral load. 
Salivary gland disease usually develops before AIDS, and 
is sometimes the first manifestation of HIV infection.(12) 
It is usually bilateral and accompanied by cervical lympha-
denopathy. Computed tomographic scans often identify 
multiple parotid cysts. 
Pathologic features. Parotid gland disease resembles both 
persistent generalized lymphadenopathy and lymphoepi-
thelial sialadenitis. Florid lymphoid follicular hyperplasia 
replaces normal parotid parenchyma. Many lymphoid 
follicles are large and irregularly shaped with attenuated 
mantles and follicle lysis and contain numerous tingible 
body-macrophages and mitotic figures. The extra-follicular 
tissue contains many histiocytes, clusters of large mono-
morphic, pale round cells, neutrophils, and plasma cells. 
Lymphoepithelial cysts and lymphoepithelial lesions (see 
Lymphoepithelial Sialadenitis) are usually numerous. 
Evaluation Factors: 
I. Ocular symptoms: at least one of: 
1. Daily dry eyes for more than 3 months 
2. Sensation of sand or gravel in eyes 
3. Use of tear substitutes more than 3 times a day 
II. Oral symptoms: at least one of: 
1. Dry mouth for more than 3 months 
2. Recurrent or persistent swelling of salivary glands 
3. Liquids needed to aid swallowing dry food 
III. Ocular signs: at least one of: 
1. Schirmer’s I test, without anesthesia,  5 mm in 5 minutes 
2. Positive vital dye staining 
IV. Labial salivary gland biopsy: focus score§  1 
V. Salivary gland involvement: at least one of: 
1. Unstimulated whole salivary flow  1.5 ml in 15 minutes 
2. Parotid sialography with diffuse sialectasias without 
obstruction of major ducts 
3. Salivary scintigraph with delayed uptake, reduced 
concentration and/or delayed excretion of tracer 
VI. Autoantibodies to Ro(SSA) or La(SSB) in serum 
Classification:
Primary SS 
a. Any 4 of 6 positive evaluation factors, as long as IV or VI is 
positive
b. Any 3 of positive evaluation factors III, IV, V, and VI 
Secondary SS 
Positive evaluation factor I or II plus any 2 of positive factors 
III, IV, and V 
Exclusions:
Radiation to head and neck 
Hepatitis C infection 
Acquired immunodeficiency syndrome 
Lymphoma
Sarcoidosis
Graft versus host disease 
Use of anticholinergic drugs 
§A focus is an aggregate of 50 or more lymphocytes in the salivary gland; 
the focus score is the number of foci per 4 mm2 of salivary gland tissue.
table 1. American-European classification criteria for Sjögren syndrome 
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The majority of  intraepithelial lymphocytes are CD20+ 
centrocyte-like B-cells while most other extra-follicular 
lymphocytes are CD8+ T-cells.(13) Follicular dendritic 
cells and interfollicular macrophages are positive for p24 
core antigen of HIV. 
Prognosis. Regression of parotid gland swelling after initia-
tion of anti-viral therapy has been reported.(12)
Differential Diagnosis. While the described histopathologic 
features are characteristic of HIV-associated salivary gland 
disease, similar features occur in some cases of HIV-nega-
tive lymphoepithelial sialadenitis. Clinical testing for HIV 
infection is needed to confirm a diagnosis of HIV-associated 
salivary gland disease.
chronIc scLErosInG sIALAdEnItIs
Chronic sclerosing sialadenitis is a chronic inflammation of 
salivary gland that progresses with increasing fibrosis and 
parenchymal atrophy. This entity is also known as Küttner 
tumor (14)
Clinical features. It is the most common disease of  the 
submandibular gland, which it more frequently affects than 
any other salivary gland.(14) It is usually unilateral but 
sometimes bilateral. There is a slight female predilection. 
Most lesions occur in the fifth through seventh decades of 
life.(1)
Sialoliths are associated with 50 to 83% of cases, usually 
in the extraglandular excretory ducts,(15) but patients with 
bilateral disease are less likely to have sialoliths. It is not 
determined whether the sialoliths are the cause or the result 
of sialadenitis. Some cases, however, are probably immune 
disorders.(16) 
Firm swelling of  the submandibular gland is frequently 
accompanied by recurrent pain. Radiography detects most 
sialoliths, although up to 20% of  sialoliths are radiolu-
cent.(15) Durations are usually months but sometimes 
many years.
Pathologic features. Microscopic features change with 
progression of disease. Early stage disease is characterized 
by foci of chronic inflammation, usually periductal, with 
periductal fibrosis and ductal ectasia. As the disease progre-
sses, there is increased fibrosis, acinar atrophy, and ductal 
dilatation. The amount of inflammation and fibrosis varies 
from lobule to lobule, but in end stage disease the entire 
gland is fibrotic and inflammation is decreased. The infla-
mmatory infiltrate is predominantly lymphocytic, usually 
with some plasma cells and histiocytes, which sometimes 
form small granulomas. Lymphoid follicles vary from none 
to numerous. 
Prognosis. Removal of  sialoliths, with surgery or litho-
tripsy,(17) in extraglandular salivary ducts often resolves 
early stage disease. In later stage disease, gland excision is 
necessary. 
Differential Diagnosis. Sarcoidosis of salivary gland is cha-
racterized by several epithelioid granulomas and less fibrosis 
and ductal ectasia. Lymphoepithelial complexes distinguish 
lymphoepithelial sialadenitis. Immunohistochemical stai-
ning for markers such as CD10 and Bcl2 help differentiate 
follicular lymphoma from chronic sclerosing sialadenitis 
with numerous lymphoid follicles.
LyMphoEpIthELIAL cArcInoMA
Lymphoepithelial carcinoma is a large cell undifferentiated 
carcinoma embedded within a dense lymphoid stroma. The 
histopathologic features and propensity for tumor cells to be 
infected with Epstein-Barr virus (EBV) are quite similar to 
nonkeratinizing nasopharyngeal carcinoma with lymphoid 
stroma.(1)
Clinical features. Although it constitutes only 0.4 percent 
of salivary gland neoplasms, there are unique and distinct 
geographic and ethnic differences in incidence. Over 75% 
of patients have been arctic native people from Greenland, 
Canada, and Alaska and Asians, mostly Southern Chinese, 
and familial clustering has been reported.(18,19). There 
is a slight predilection for women except among Chinese. 
Patients have ranged from young to old.(1) The parotid 
gland is primarily affected although a few tumors occur in 
the submandibular gland.
EBV infection of the malignant epithelial cells is demons-
trable in most lymphoepithelial carcinomas, although less 
frequently in Caucasian patients.(18,20) The methodology 
of testing for EBV can affect the results, and in situ hy-
bridization for EBV-encoded RNA 1 (EBER1) is one of 
the more sensitive tests.(18) While most lymphoepithelial 
carcinomas arise de novo, a few occur in lymphoepithelial 
sialadenitis.(1)
Discomfort, pain, or facial nerve palsy sometimes accom-
pany swelling in the parotid or submandibular gland. Cer-
vical lymphadenopathy is common.(18) Tumors’ durations 
have ranged from months up to 10 years.(1)
Pathologic features. At low-magnification, a lymphoid-dense 
stroma, often with germinal centers, is most conspicuous. At 
higher magnification, irregular shaped aggregates of large 
epithelial cells within the lymphocyte-rich stroma become 
more readily evident. These epithelial cells are polygonal to 
slightly spindled cells with amphophilic to eosinophilic cyto-
plasm, large, round to oval, lightly basophilic to vesicular 
nuclei, and, often, one or more prominent nucleoli. They are 
variably arranged as small nests, cords, trabeculae, syncytial 
masses with indistinct cell borders, or isolated cells. Mito-
tic figures vary from few to numerous. The lymphoid-rich 
stroma is a mixture of lymphocytes and plasma cells that 
surround and permeate the carcinoma cells. The amount of 
collagenous stroma varies.
A few tumors are associated with lymphoepithelial sialade-
nitis, and such tumors have lymphocyte-permeated nests of 
benign epithelium in addition to carcinoma. This benign epi-
thelium has smaller cells that lack pleomorphism, vesicular 
nuclei, prominent nucleoli, and mitotic figures and often has 
intercellular deposits of eosinophilic hyalin material. 
The carcinomatous cells are immunoreactive for cytokera-
tin and epithelial membrane antigen. In situ hybridization 
for EBV encoded RNA 1 (EBER1) and for EBV DNA is 
positive in almost all tumors from Asian patients.(18) Some 
tumors from non-Asians and non-Arctic native people are 
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also positive.(1) They are reactive for EBV latent membrane 
1 in 50 to 60 percent of tumors that are positive for EBV-
encoded RNA 1 by in-situ hybridization.(20) Lymphoid 
markers confirm the benign nature of  the lymphocytic 
infiltrate.
Prognosis. About 40% and 20% of tumors metastasize to 
cervical lymph nodes and distant sites, respectively, and 
both events indicate an adverse outcome. Histologic indi-
cators of poor prognosis are high mitotic rate, anaplasia, 
and necrosis. However, over 60% of patients survive when 
treated with surgery, including neck dissection, and radia-
tion therapy.(18)
Differential Diagnosis. The histopathologic, histochemi-
cal, immunohistochemical, ultrastructural, and molecular 
features of nonkeratinizing, undifferentiated nasopharyn-
geal carcinoma of the so-called lymphoepithelioma type 
and lymphoepithelial carcinoma of the salivary gland are 
practically indistinguishable from one another. Fortunately, 
the parotid gland is an infrequent site of metastasis for na-
sopharyngeal carcinoma. Still, thorough evaluation of the 
nasopharynx and Waldeyer’s ring region may be needed. 
Lymphoepithelial sialadenitis lacks cytologic features of 
malignancy and invasion of adjacent tissues. Metastatic 
amelanotic melanoma to intraparotid lymph nodes often 
requires immunostaining for cytokeratin, S100 protein, 
HMB45, Melan A, and tyrosinase to determine the correct 
diagnosis. Likewise, lymphoid and histiocytic immunohis-
tochemical markers help differentiate large cell lymphocytic 
and histiocytic neoplasms.(1)
Small cell carcinoma of salivary gland is a rare, primary 
malignant tumor that is composed of small, undifferentiated 
cells, usually exhibits focal neuroendocrine differentiation, 
and occasionally has small areas of better differentiated 
carcinoma or adenocarcinoma. The tumor cells have a 
characteristic paranuclear, globular staining pattern with 
anti-cytokeratin (AE1/3 and CK20). They are variably 
immunoreactive for Leu-7 (CD57), CD56, synaptophysin, 
chromogranin A, epithelial membrane antigen, neuro-
filament, and neuron-specific enolase, but most express 
one marker indicating neuroendocrine differentiation.(1) 
Immunoreactivity for cytokeratin and lack of reactivity for 
lymphoid markers facilitate distinction from lymphoma. 
Distinction from metastatic pulmonary oat cell carcinoma 
and Merkel cell carcinoma is difficult and largely relies on 
clinical evaluation. About 20 percent of salivary small cell 
carcinoma may also express thyroid transcription factor-1 
(TTF-1).(1) These tumors lack the prominent lymphoid 
component that characterizes lymphoepithelial carcino-
ma.
Large cell undifferentiated carcinoma of salivary gland is a 
malignant epithelial neoplasm that lacks histomorphologic 
features of either glandular or epidermoid differentiation 
and cannot be characterized as any other type of salivary 
gland carcinoma. The tumor cells are much larger than those 
of small cell carcinoma but similar to those in lymphoepi-
thelial carcinoma. Rarely, there are bizarre, osteoclast-like, 
multinucleated giant cells. Mitotic figures are typically com-
mon. Invasion of adjacent tissues is characteristic. They lack 
the prominent lymphoid component of lymphoepithelial 
carcinoma, and in situ hybridization for Epstein-Barr virus 
RNA has been negative.(18) They are typically reactive for 
cytokeratins and have a high prevalence of c-erbB-2 im-
munoreactivity. Rapid growth, short duration, and cervical 
lymphadenopathy are typical. The prognosis is worse than 
for lymphoepithelial carcinoma.
WArthIn tuMor
Warthin tumor is an adenoma composed of  bilayered 
columnar and basaloid oncocytic epithelium that forms 
multiple cysts with numerous papillae accompanied by a 
proliferation of follicle-containing lymphoid tissue. It occurs 
almost exclusively in the parotid gland.(1) The older term 
papillary cystadenoma lymphomatosum is descriptively 
accurate and synonymous with the eponymic term Warthin 
tumor. Adenolymphoma and cystadenolymphoma are other 
terms that have been used, but their use is discouraged to 
avoid confusion with lymphoid malignancy.
Clinical features. It is the second most common benign 
parotid salivary gland tumor.(1,21) Nearly all Warthin 
tumors occur in the parotid gland or periparotid region. 
Most involve the tail of the gland, but about 10 percent 
occur in the deep lobe. Rare examples occur in sites other 
than the parotid gland. 
Historically, it has been conceptualized that Warthin tumor 
is a neoplasm that develops from heterotopic salivary ducts 
trapped within intraparotid or paraparotid lymphoid tissue. 
A more likely explanation is that it is a metaplastic process 
with a secondary lymphoid reaction. In support of this pro-
posal is the finding that several other benign and malignant 
salivary gland tumors appear to incite a prominent tumor-
associated lymphoid proliferation.(22). The observation 
that multicentric growth occurs more often with Warthin 
tumor than any other salivary gland tumor argues against 
coincidental intra-nodal development.(23) Perhaps both 
pathogeneses occur. 
Smokers have eight times the risk of developing Warthin 
tumor than nonsmokers, and patients with Warthin tumor 
are heavier smokers than patients who develop pleomorphic 
adenomas.(24) 
Recent studies note a reduced male predilection ratio of 
between 1.1:1 and 1.6:1 from the previously reported marked 
male predominance.(23) The decreasing male predilection 
from previous eras may be related to the increasing pro-
portion of female smokers.  The average age of patients is 
62 years.(1) Less than 6 percent of Warthin tumors occur 
before the age of 40 years. 
Warthin tumors are usually painless, fluctuant swellings in 
the lower portion of the parotid gland. Mild to severe pain is 
experienced by about 9 percent of patients. Earache, tinnitus, 
and deafness also occur. Most are 2-4 cm in diameter, but 
they sometimes are considerably larger. Secondary infla-
mmation following rupture of a cyst obscures the usually 
well-defined borders of the tumor.
Warthin tumor concentrates sodium pertechnetate (99mTc), 
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making it amenable to scintigraphic examination.(25) On-
cocytomas, however, also concentrate 99mTc. 
Pathologic features. Warthin tumor is spherical to ovoid 
and nearly always well circumscribed except when secon-
darily inflamed. The cut surface of the tumor has a variable 
number of cysts that exude clear, mucoid, or brown fluid 
or caseous, semisolid debris. The cysts vary from small to 
large slit-like spaces and lumens of the cysts have small, 
knob-like excrescences. The intercystic areas are composed 
of small tan to white nodular foci and, occasionally, contain 
focal hemorrhage. 
Microscopically, cystic spaces are lined by a papillary 
proliferation of  bilayered, oncocytic epithelium whose 
supporting stroma is composed largely of  lymphoid tis-
sue. The luminal epithelium is tall, columnar cells whose 
centralized or apical ovoid nuclei often align in a palisade. 
The cytoplasm is finely granular and brightly eosinophilic. 
The granularity is due to abundant mitochondria, which is 
verifiable with phosphotungstic acid-hematoxylin stain or 
electron microscopy. Beneath and between the columnar ce-
lls are less obvious, smaller basaloid cells that have granular 
eosinophilic cytoplasm similar to that of the columnar cells. 
In some tumors, there are also scattered mucous, squamous, 
or sebaceous cells. Fibrovascular stroma that contains a den-
se component of small lymphocytes supports the epithelium. 
In a majority of tumors, there are well formed germinal 
centers and mantle zones. Rarely, tumors have undergone 
carcinomatous or lymphomatous transformation of  the 
epithelial or lymphoid elements, respectively.(26,27)
A study with polymerase chain reaction found no dominant 
B- or T-cell clonal populations, but a minor clonal expansion 
of both B and T cells was detected in some tumors. (28) 
Identification of follicular dendritic cells suggests that they 
have an immunological role in Warthin tumor.
Reported increased levels of base pair deletions in mitochon-
drial DNA in Warthin tumor may be related to oxidative 
damage that occurs with smoking.(29) In one study, 11of 12 
cases had no evidence of clonal allelic loss, supporting the 
hypothesis that these lesions are non-neoplastic.(30)
Prognosis. Most studies indicate a recurrence rate of 
two percent or less.(1) Some recurrences may actually be 
multifocal occurrence. 
Differential Diagnosis. The cystic, papillary oncocytic epi-
thelium and associated lymphoid element are so characte-
ristic that the diagnosis is usually straightforward. Focal 
oncocytic hyperplasia, mucocyte hyperplasia, and squamous 
metaplasia occur in a few tumors. There is a wide variation 
in the proportion of epithelial and lymphoid components. 
Some cystadenomas have papillary, oncocytic epithelium, 
but they lack a well organized lymphoid element. 
Sometimes Warthin tumors undergo infarction with re-
sultant necrosis, fibrosis, and squamous and mucinous 
metaplasia. In these cases, careful examination is needed to 
rule out squamous cell and mucoepidermoid carcinomas. 
Recognition of the outlines of necrotic intracystic papillae 
formed by tall columnar and basal cells is diagnostic. In 
addition, there is absence of infiltrative growth. 
Tumors with prominent tumor-associated lymphoid pro-
liferation, such as mucoepidermoid carcinoma, acinic cell 
adenocarcinoma, and cystadenocarcinoma,  have some 
similarity to Warthin tumor.(22) However, the epithelium 
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